Endogenous opiates: 1993
- PMID: 7700854
- PMCID: PMC7124241
- DOI: 10.1016/0196-9781(94)90131-7
Endogenous opiates: 1993
Abstract
This paper is the sixteenth installment of our annual review of research concerning the opiate system. It is restricted to papers published during 1993 that concern the behavioral effects of the endogenous opiate peptides, and does not include papers dealing only with their analgesic properties. The specific topics this year include stress; tolerance and dependence; eating; drinking; gastrointestinal, renal, and hepatic function; mental illness and mood; learning, memory, and reward; cardiovascular responses; respiration and thermoregulation; seizures and other neurological disorders; electrical-related activity; general activity and locomotion; development; immunological responses; and other behaviors.
Similar articles
-
Endogenous opiates: 1995.Peptides. 1996;17(8):1421-66. doi: 10.1016/s0196-9781(96)00225-2. Peptides. 1996. PMID: 8971940 Review.
-
Endogenous opiates: 1994.Peptides. 1995;16(8):1517-55. doi: 10.1016/0196-9781(95)02063-2. Peptides. 1995. PMID: 8745067 Review.
-
Endogenous opiates and behavior: 2014.Peptides. 2016 Jan;75:18-70. doi: 10.1016/j.peptides.2015.10.009. Epub 2015 Nov 10. Peptides. 2016. PMID: 26551874 Review.
-
Endogenous opiates: 1998.Peptides. 1999 Dec;20(12):1527-74. doi: 10.1016/s0196-9781(99)00166-7. Peptides. 1999. PMID: 10698131 Review.
-
Endogenous opiates: 1996.Peptides. 1997;18(10):1651-88. doi: 10.1016/s0196-9781(97)00264-7. Peptides. 1997. PMID: 9437729 Review.
Cited by
-
The effects of beta-endorphin: state change modification.Fluids Barriers CNS. 2015 Jan 29;12:3. doi: 10.1186/2045-8118-12-3. Fluids Barriers CNS. 2015. PMID: 25879522 Free PMC article. Review.
-
Pharmacokinetics and pharmacodynamics of sedatives and analgesics in the treatment of agitated critically ill patients.Clin Pharmacokinet. 1997 Dec;33(6):426-53. doi: 10.2165/00003088-199733060-00003. Clin Pharmacokinet. 1997. PMID: 9435992 Review.
-
Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides.Cell Mol Neurobiol. 1995 Dec;15(6):615-35. doi: 10.1007/BF02071128. Cell Mol Neurobiol. 1995. PMID: 8719033 Free PMC article. Review.
-
Mu opioid receptor-like sequences are present throughout vertebrate evolution.J Mol Evol. 1996 Sep;43(3):179-84. doi: 10.1007/BF02338825. J Mol Evol. 1996. PMID: 8703083
References
-
- Abrahamsen G.C., Stock H.S., Calderone B.J., Schutz A.D., Rosellini R.A. Conditioned fear exacerbates acute precipitation of the morphine withdrawal syndrome. Soc. Neurosci. Abstr. 1993;19:370.
-
- Aceto M.D., Scates S.M., Ji Z., Bowman E.R. Nicotine's opioid and anti-opioid interactions: Proposed role in smoking behavior. Eur. J. Pharmacol. 1993;248:333–335. - PubMed
-
- Ackerman J.M., Moises H.M. Withdrawal from chronic morphine treatment produces alterations in the beta-adrenergic receptor-coupled adenylate cyclase system. Soc. Neurosci. Abstr. 1993;19:1248.
-
- Acquas E., Meloni M., Di Chiara G. Blockade of δ-opioid receptors in the nucleus accumbens prevents ethanol-induced stimulation of dopamine release. Eur. J. Pharmacol. 1993;230:239–241. - PubMed
-
- Aghajanian G.K., Kogan J.H., Moghaddam B. Increased glutamate release in the locus coeruleus (LC) during opiate withdrawal: A microdialysis study. Soc. Neurosci. Abstr. 1993;19:1247.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources